Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Evaluation of ADG20 for the Prevention of COVID-19

ClinicalTrials.gov ID: NCT04859517

Public ClinicalTrials.gov record NCT04859517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 7:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Randomized, Double-blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of ADG20 in the Prevention of COVID-19 (EVADE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This placebo-controlled study is intended to evaluate ADG20's safety and ability to prevent COVID-19 infection.

Study identification

NCT ID
NCT04859517
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Invivyd, Inc.
Industry
Enrollment
2,582 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 27, 2021 (Actual)
Primary completion
Nov 4, 2022 (Actual)
Completion
Nov 4, 2022 (Actual)
Last update posted
Aug 20, 2024

2021 – 2022

United States locations

U.S. sites
66
U.S. states
25
U.S. cities
63
Facility City State ZIP Site status
Invivyd Investigative Site Birmingham Alabama 35209 —
Invivyd Investigative Site Tucson Arizona 85745 —
Invivyd Investigative Site Fayetteville Arkansas 72701 —
Invivyd Investigative Site North Little Rock Arkansas 72223 —
Invivyd Investigative Site Banning California 92220 —
Invivyd Investigative Site Chula Vista California 91911 —
Invivyd Investigative Site Culver City California 90230 —
Invivyd Investigative Site Escondido California 92025 —
Invivyd Investigative Site Fullerton California 92835 —
Invivyd Investigative Site Long Beach California 90806 —
Invivyd Investigative Site Los Angeles California 90036 —
Invivyd Investigative Site Modesto California 95350 —
Invivyd Investigative Site Palm Springs California 92262 —
Invivyd Investigative Site San Diego California 92103 —
Invivyd Investigative Site Clearwater Florida 33756 —
Invivyd Investigative Site Edgewater Florida 32132 —
Invivyd Investigative Site Hialeah Florida 33012 —
Invivyd Investigative Site Miami Florida 33155 —
Invivyd Investigative Site Miami Florida 33176 —
Invivyd Investigative Site Miami Florida 33186 —
Invivyd Investigative Site Mt. Dora Florida 32757 —
Invivyd Investigative Site North Miami Beach Florida 33169 —
Invivyd Investigative Site Ormond Beach Florida 32174 —
Invivyd Investigative Site Pembroke Pines Florida 33026 —
Invivyd Investigative Site Sunrise Florida 33325 —
Invivyd Investigative Site Tampa Florida 33603 —
Invivyd Investigative Site The Villages Florida 32159 —
Invivyd Investigative Site West Palm Beach Florida 33409 —
Invivyd Investigative Site Hinesville Georgia 31313 —
Invivyd Investigative Site Lawrenceville Georgia 30044 —
Invivyd Investigative Site Pearl City Hawaii 96782 —
Invivyd Investigative Site Chicago Illinois 60607 —
Invivyd Investigative Site Oak Brook Illinois 60523 —
Invivyd Investigative Site Owensboro Kentucky 42303 —
Invivyd Investigative Site Marrero Louisiana 70072 —
Invivyd Investigative Site New Orleans Louisiana 70118 —
Invivyd Investigative Site Rockville Maryland 20855 —
Invivyd Investigative Site Burlington Massachusetts 01803 —
Invivyd Investigative Site Caro Michigan 48723 —
Invivyd Investigative Site Grosse Pointe Woods Michigan 48236 —
Invivyd Investigative Site Missoula Montana 59808 —
Invivyd Investigative Site Albuquerque New Mexico 87102 —
Invivyd Investigative Site New York New York 11201 —
Invivyd Investigative Site Charlotte North Carolina 28208 —
Invivyd Investigative Site Shelby North Carolina 28150 —
Invivyd Investigative Site Beachwood Ohio 44122 —
Invivyd Investigative Site Cincinnati Ohio 54242 —
Invivyd Investigative Site Dresden Ohio 43821 —
Invivyd Investigative Site Middleburg Heights Ohio 44130 —
Invivyd Investigative Site Yukon Oklahoma 73099 —
Invivyd Investigative Site Medford Oregon 97504 —
Invivyd Investigative Site West Columbia South Carolina 29169 —
Invivyd Investigative Site Jackson Tennessee 38305 —
Invivyd Investigative Site Milan Tennessee 38358 —
Invivyd Investigative Site Nashville Tennessee 37203 —
Invivyd Investigative Site Beaumont Texas 77706 —
Invivyd Investigative Site College Station Texas 77845 —
Invivyd Investigative Site Corpus Christi Texas 78412 —
Invivyd Investigative Site Houston Texas 77022 —
Invivyd Investigative Site Houston Texas 77087 —
Invivyd Investigative Site Hurst Texas 76054 —
Invivyd Investigative Site Mesquite Texas 75149 —
Invivyd Investigative Site Sugar Land Texas 77479 —
Invivyd Investigative Site St. George Utah 84790 —
Invivyd Investigative Site West Jordan Utah 84088 —
Invivyd Investigative Site Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04859517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2024 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04859517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →